A Systematic In Silico Search for Target Similarity Identifies Several Approved Drugs with Potential Activity against the Plasmodium falciparum Apicoplast-Reference-Cited by-同舟云学术

A Systematic In Silico Search for Target Similarity Identifies Several Approved Drugs with Potential Activity against the Plasmodium falciparum Apicoplast

Published:2013-03-26 Issue:3 Volume:8 Page:e59288
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bispo Nadlla Alves,Culleton Richard,Silva Lourival Almeida,Cravo Pedro

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. World Health Organization (2011) World Malaria Report 2011. WHO: Geneva. http://www.who.int/malaria/world_malaria_report_2011/9789241564403_eng.pdf.

2. Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance;CJ Woodrow;Cell Mol Life Sci,2006

3. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum;J Le Bras;Fundam Clin Pharmacol,2003

4. Malaria and other Apicomplexans: the "plant" connection;RJ Wilson;Infect Agents Dis,1994

5. Plastid in human parasites;GI McFadden;Nature,1996

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A critical analysis of the binding pocket of Plasmodium falciparum Phosphatidylinositol‐4‐kinase enzyme;ChemistrySelect;2023-11-15

2. Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates;Molecules;2022-04-23

3. An Allosteric Inhibitory Potential of Triterpenes fromCombretum racemosumon the Structural and Functional Dynamics ofPlasmodium falciparumLactate Dehydrogenase Binding Landscape;Chemistry & Biodiversity;2022-01-04

4. Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for Plasmodium falciparum and P. vivax;Antimicrobial Agents and Chemotherapy;2020-08-20

5. Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs;Expert Review of Anti-infective Therapy;2020-05-20